Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products, and services in the sectors of test and measurement, environmental, life sciences, dental, and industrial technologies.
Website: danaher.com


  • Good financial results growth rate 136.9% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-2.1%)
  • Dividend yield for the last twelve months 0.6%
  • Free cash flow yield -0.8% (LTM)
  • Share price is 10.2% higher than minimum and 32.5% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (28.9x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $1.4 mln (-0.001% of cap.)

Key Financials (Download financials)

Ticker: DHR
Share price, USD:  (-0.5%)204.02
year average price 245.18  


year start price 245.94 2024-04-02

max close price 280.76 2024-08-01

min close price 201.62 2025-02-11

current price 204.02 2025-04-01
Common stocks: 727 076 992

Dividend Yield:  0.6%
FCF Yield LTM: -0.8%
EV / LTM EBITDA: 28.9x
EV / EBITDA annualized: 25.3x
Last revenue growth (y/y):  +142.8%
Last growth of EBITDA (y/y):  +130.9%
Historical revenue growth:  +2.0%
Historical growth of EBITDA:  -6.1%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 148 338
Net Debt ($m): 13 934
EV (Enterprise Value): 162 272
EBITDA LTM ($m): 5 609
EV / LTM EBITDA: 28.9x
Price to Book: 2.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-03-31seekingalpha.com

Danaher Corporation: A Mixed Bag Of Strength And Stagnation

2025-03-30seekingalpha.com

Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations

2025-03-22seekingalpha.com

Danaher: Near 5-Year Low Is A Great Entry Point

2025-03-20prnewswire.com

Danaher Schedules First Quarter 2025 Earnings Conference Call

2025-02-24zacks.com

Danaher Rewards Shareholders With 18.5% Dividend Increase

2025-02-20prnewswire.com

Danaher Announces Appointment of Charles Lamanna to Danaher Board

2025-02-17seekingalpha.com

Danaher: Self-Inflicted Pessimism?

2025-01-29zacks.com

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y

2025-01-29zacks.com

Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say

2025-01-29seekingalpha.com

Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data